When comparing PRP and exosome therapy, there’s one important fact clinics rarely mention upfront: exosome products have no approvals from the U.S. Food and Drug Administration (FDA). PRP falls into a murkier category: the prep kits are cleared but the treatment itself is not. That difference in oversight matters more than the marketing claims and is a good reason to pause before choosing either option.
This guide also compares PRP and exosome therapy with stem cell therapy, hair transplants, and microneedling, since clinics increasingly promote all five for many of the same joint and hair concerns. Growth factor concentrate (GFC) and mesotherapy often appear in those searches as well, so we’ll explain where they fit.
Of all the treatments covered in our guides, exosome therapy tends to generate the most questions from readers who have already looked into the cost of PRP and stem cells. None is a cure, and none of the five options below is FDA-approved for joint conditions, hair concerns, or anti-aging.
PRP vs Exosome Therapy, Stem Cells, Hair Transplant & Microneedling at a Glance
| Option | What it is | Typical US cost | FDA status | Evidence |
|---|---|---|---|---|
| PRP | Concentrated platelets from your own blood | $400–$2,000/session, $1,500–$6,000/course | Prep kits cleared as devices, treatment itself not approved | Mixed, the largest evidence base of the five |
| Exosome therapy | Donor- or lab-derived cell-signal particles | $1,000–$5,000+ per treatment | Zero approvals, FDA safety warnings issued | Weak, almost no controlled human trials |
| Stem cell therapy | Living cells from fat, marrow, or donor tissue | $5,000–$25,000+ | Narrow approvals for blood/immune disease only | Limited, mostly small or early-stage studies |
| Hair transplant | Surgical relocation of your own hair follicles | $4,000–$15,000+, scales with grafts | Surgical procedure, not FDA drug-regulated | Well-documented surgical outcomes literature |
| Microneedling | Mechanical micro-injury to trigger a healing response | $200–$700/session, $600–$4,200/course | Devices cleared for other skin uses, not hair regrowth specifically | Limited, strongest when combined with minoxidil |
The pattern holds across nearly every use clinics sell: price tends to rise with how much biological material is involved, and FDA oversight tends to shrink the newer and less standardized the product is.
Two rows need a footnote. A hair transplant does not go through an FDA drug-approval process at all, because it moves follicles you already have rather than injecting a biologic. Microneedling devices used on the scalp usually hold FDA clearance for a different skin indication entirely, so using one for hair is an off-label use of an on-label device.
What Each Option Is
These five get marketed together, but they are built from genuinely different material, and that difference drives almost everything else on this page.
PRP is platelet-rich plasma. A provider draws your blood, spins it in a centrifuge, and concentrates the platelets, which release growth factors, the signals your body uses in healing. PRP contains no living stem cells and no donor tissue.
Exosome therapy injects tiny particles, smaller than a cell, that cells use to signal one another. Products sold in clinics usually come from donor placental or umbilical tissue, or from lab-grown cells, not from your own blood.
Stem cell therapy uses whole living cells, harvested from your own fat or bone marrow, or bought as a donor product. Living cells are a more complex product than either platelets or signal particles, which is part of why they cost more.
A hair transplant is outpatient surgery. A surgeon moves follicles that resist the hormone behind pattern baldness from a donor area into thinning spots, using a strip or individual-follicle technique.
Microneedling uses fine needles to create controlled micro-injury in the skin or scalp, on the theory that the healing response that follows can support collagen or hair growth. It carries no biologic product at all, only mechanical injury and, often, a topical serum applied alongside it.
Cost: Exosome Therapy Against Every Alternative
Exosome therapy looks worst on cost of any option on this page, which is a big part of why patients search for this comparison. A single exosome treatment runs $1,000 to $5,000, more than double a typical PRP session at $400 to $2,000.
Run the arithmetic for a joint or scalp problem needing repeat visits. A three-session PRP course at $900 each totals $2,700. Three exosome treatments at $2,500 each totals $7,500, nearly triple, for a product with no FDA approval behind it. Stem cell therapy sits above both at $5,000 to $25,000 or more, usually for one or two visits rather than a repeating course.
A hair transplant is the one option here priced as a single procedure rather than a repeating course. Budget $4,000 to $15,000 or more, scaling with how many grafts you need, but there is no ongoing injection cost afterward the way PRP, exosomes, and stem cells all require. Microneedling is the cheapest single option, $200 to $700 per session, with a full course landing between $600 and $4,200.
FDA Status: the Detail Most Clinics Blur
FDA status is the single clearest signal of how much oversight stands between you and the product going into your body, and the five options split into very different tiers.
PRP’s preparation kits, the tubes and centrifuges that separate the platelets, have FDA device clearance. That clearance covers the equipment, not the treatment. The FDA has not approved PRP itself as a treatment for any joint, hair, or skin use, so a doctor offers it off-label under the ordinary practice of medicine.
Exosome products have no FDA approvals of any kind, and the agency has said so directly. A public safety notification on exosome products describes patients in Nebraska who developed serious infections, including sepsis, after an unapproved exosome product in 2019. The FDA’s broader safety alert on unapproved stem cell and exosome products warns that sellers may face seizure or injunction, and enforcement has continued since. The FDA sent a warning letter to a cord-tissue and exosome manufacturer in September 2025, stating its products, including an exosome line, are unapproved drugs and unlicensed biologics marketed for orthopedic and neuropathy uses they were never reviewed for. Most recently, in August 2026, the FDA sent a warning letter to R3 Medical Companies for marketing exosome products under the argument that a cell-free product falls outside biologic regulation. The FDA rejected that argument.
Stem cell therapy has narrow, named approvals, mostly blood and immune disorders, plus a small number of specific cell products. Joints, hair, and anti-aging are the uses most clinics sell, and none of them are covered by those approvals.
A hair transplant is not evaluated through the FDA drug pathway at all, since a surgeon relocating your own tissue is not a biologic product. Microneedling devices themselves often do hold FDA clearance, but typically for a different labeled use, such as facial scarring, not scalp hair regrowth, so using one on the scalp for hair sits outside that device’s actual clearance.
Evidence: Thin Across the Board
Evidence quality is the second axis that separates these five, and it does not track neatly with price. A pricier option is not automatically a better-studied one.
PRP has the deepest evidence base of the five, though “deepest” here still means mixed. A 2026 meta-analysis of knee osteoarthritis trials found PRP often beat placebo and hyaluronic acid for pain, with results swinging on how the PRP was prepared. A 2025 systematic review of alopecia trials rated PRP’s hair-loss evidence as moderate.
Exosome therapy has the thinnest evidence of any option here. Most published research is cell-culture or animal work rather than controlled human trials, and no large trial has shown a benefit for joints, hair, or anti-aging in people.
Stem cell therapy sits between the two. A 2025 Cochrane review of knee osteoarthritis injections found a possible small benefit over placebo, on low-certainty evidence, with no proof of new cartilage growth.
A hair transplant is the odd one out. Its evidence is surgical outcomes literature, not a biologic-efficacy question, since the procedure simply relocates hair-producing follicles that already resist balding. That distinction matters: a hair transplant answers “did the moved follicles keep growing,” a question surgery answers well, while PRP, exosomes, and stem cells all answer the far harder question of whether an injection changes the underlying biology.
Microneedling’s evidence for hair sits closest to exosome therapy’s, thin and mostly small studies, and it strengthens mainly when paired with minoxidil rather than tested alone.
PRP vs Exosome Therapy Specifically
Set PRP against exosome therapy directly, and PRP wins on every axis that matters before you pick a clinic. It costs less, uses your own blood instead of a donor or lab product, has more published evidence, and its prep kits at least have FDA device clearance behind them.
Exosome therapy’s one selling point is novelty. Clinics pitch it as a next-generation upgrade over PRP, often at two to three times the price, without the mention that no exosome product has FDA approval and that the FDA has linked unapproved versions to real patient harm. If you are drawn to regenerative injections at all, PRP is the more conservative entry point of the two.
Exosome Therapy vs Stem Cell Therapy
Exosome therapy and stem cell therapy get bundled together in marketing, but their regulatory pictures differ more than the price tags suggest. Stem cell therapy at least has a narrow set of named FDA approvals, even if none cover joints or hair. Exosome therapy has none at all.
Stem cell therapy also costs more per treatment, typically $5,000 to $25,000 against exosome therapy’s $1,000 to $5,000, so the two rarely compete for the same budget. Our PRP vs stem cell guide breaks that specific comparison down in full, including the evidence gap between the two.
Exosome Therapy vs a Hair Transplant
For hair loss specifically, exosome therapy and a hair transplant solve different problems on different timelines. A hair transplant is a one-time surgical cost that relocates follicles permanently, once they take. Exosome injections need to be repeated indefinitely to hold any effect, and no exosome product has FDA approval for hair regrowth or anything else.
The real trade-off is upfront cost versus a repeating bill. A transplant runs $4,000 to $15,000 once. A repeating exosome course can approach or exceed that total over a few years without ever reaching a permanent result. Our PRP for hair loss guide covers the lower-cost injectable alternative in more depth, including how it compares with a transplant on its own terms.
Exosome Therapy vs Microneedling and Mesotherapy
Microneedling and mesotherapy round out the searches people run alongside exosome therapy, and both sit well below it on cost and risk.
Microneedling is mechanical, not biologic. Fine needles create controlled micro-injury, with no donor product injected at all, which is why it is the cheapest option on this page and carries the lowest regulatory exposure.
Mesotherapy injects a mixed cocktail into the skin or scalp, often vitamins, amino acids, and hyaluronic acid, sometimes with added growth factors blended in. Formulas vary enormously between clinics, with no standard mesotherapy product and no FDA approval for the mixture as a whole. That variability is its own red flag: ask exactly what is in the syringe before any mesotherapy session, since two clinics’ “mesotherapy” can be entirely different injections.
Exosome therapy costs more than both and adds a donor-tissue product neither of the others carries.
Growth Factor Concentrate (GFC) Is a PRP Variant
Growth factor concentrate, usually marketed as GFC, is PRP processed one step further. It is a refinement, not a separate technology. The blood is drawn and centrifuged as with standard PRP, then a platelet-activating solution isolates the growth factors and strips out red and white blood cells, often using a branded kit.
The published evidence for GFC is thinner than for standard PRP. A 2024 case series from India followed five patients for eight weeks and reported improved hair density on trichoscopy, useful as an early signal but far short of the larger PRP trials cited above. If a clinic markets GFC as more advanced than PRP, ask what specific evidence supports that claim beyond the branding, since the underlying process is a refinement of the same platelet concentrate, not a new modality.
Who This Is Not For
None of these five options is a fit if you are looking for a proven cure for arthritis, hair loss, or aging, since none carries that kind of evidence. Exosome therapy specifically is a poor fit for anyone with a weakened immune system or an active infection, given the FDA’s documented infection cases in donor-tissue products. It is also a weak choice for anyone unwilling to accept an unapproved product with no established safety review, regardless of price.
What Would Change This Answer
A large, FDA-reviewed trial showing exosome therapy is both safe and effective for a specific condition would move it out of last place on this page. The current gap is regulatory. It is not a theoretical worry. Short of that trial, a documented pattern of serious harm tied specifically to PRP, at a scale not yet seen with exosomes, would flip PRP’s current advantage. Neither has occurred as of this writing.
A Decision Framework
Match the option to your budget, your condition, and how much regulatory uncertainty you are willing to accept, in that order.
- Start with the evidence for your specific use. PRP has the most support for knees and hair. A hair transplant has the most support for permanent hair loss specifically.
- Price the full course, not one session. PRP, exosomes, and microneedling all typically need repeat visits. A hair transplant and most stem cell protocols are usually one procedure.
- Check the FDA status directly. Ask any clinic whether the specific product has any FDA approval, and expect “no.” That answer is common here and is not, by itself, a red flag.
- Weight exosome therapy’s added risk. Its donor-tissue sourcing and documented infection history make it the option that deserves the most scrutiny of the five, not the least.
- Vet the clinic before the product. See how to vet a clinic for the questions that matter regardless of which of these five you are considering.
The Bottom Line on PRP vs Exosome Therapy
PRP costs less, uses your own blood, and carries more evidence than exosome therapy, which has zero FDA approvals and a documented infection history behind it. Stem cell therapy and a hair transplant solve different problems at different price points, and microneedling is the low-cost, low-risk option if your case is mild enough to try it first. Price the full course for whichever option fits your condition, confirm its actual FDA status yourself, and read how to vet a clinic before you pay a deposit for any of the five.
Frequently asked questions
Which costs more, exosome therapy or PRP?
Exosome therapy costs more. A single exosome treatment typically runs $1,000 to $5,000, while a full PRP course of two to four sessions runs $1,500 to $6,000 total, and a single PRP session alone is usually $400 to $2,000. Neither is covered by insurance for joints, hair, or anti-aging, so both come entirely out of pocket.
Is exosome therapy or PRP more likely to be FDA-approved?
Neither is FDA-approved as a treatment, but the gap in oversight is wide. PRP's preparation kits have FDA device clearance, and doctors offer PRP off-label under the normal practice of medicine. Exosome products have zero FDA approvals of any kind, and the FDA has issued public warnings after documented patient harm.
Should I choose PRP, exosomes, stem cells, or a hair transplant?
Match the choice to your budget and your tolerance for regulatory uncertainty, not to which one a clinic markets hardest. PRP is the lower-cost, better-studied starting point for joints and hair. A hair transplant is the only option here with a well-established surgical track record for permanent hair loss. Stem cell therapy and exosome therapy carry the least evidence and the least oversight, in that order, with exosomes the more exposed of the two.
Is growth factor concentrate (GFC) the same thing as PRP?
Yes, essentially. GFC is PRP processed a step further, isolating the growth factors and stripping out red and white blood cells, usually with a branded kit. It is not a separate treatment category, and the published evidence for it is even thinner than for standard PRP, mostly small case series rather than large trials.
Is exosome therapy safer than PRP?
No. PRP uses your own freshly drawn blood, which keeps infection risk low. Exosome products usually come from donor or lab sources, and the FDA has linked unapproved exosome products to serious infections, including sepsis. On safety alone, PRP is the more conservative choice of the two.
How does exosome therapy compare with a hair transplant for hair loss?
A hair transplant surgically relocates follicles you already have and does not need repeat sessions to hold the result. Exosome injections for hair loss need to be repeated, are not FDA-approved for any use, and have a thinner evidence base than PRP for the same purpose. Cost and permanence, not marketing language, are the real trade-off between the two.
What is the difference between exosome therapy and mesotherapy?
Mesotherapy injects a mixed cocktail, often vitamins, amino acids, and hyaluronic acid, sometimes with added growth factors, into the skin or scalp. Exosome therapy injects a single class of cell-signal particles, usually from donor tissue. Mesotherapy formulas vary enormously by clinic, with no standard product. Exosome products, whatever their source, share one fact: none of them are FDA-approved.
Does microneedling work as well as exosome therapy for hair loss?
The two are not close substitutes on cost or risk. Microneedling is a mechanical skin treatment, typically $200 to $700 per session, with the strongest evidence when paired with minoxidil rather than used alone. Exosome therapy costs more per treatment and carries no FDA approval and a documented infection history. Neither is a proven cure for hair loss on its own.
Can exosomes and PRP be combined?
Some clinics sell a combined package, layering exosomes on top of a PRP injection. There is no strong evidence the combination beats PRP alone, and it adds an unapproved product's cost and risk to a treatment that already carries no FDA approval for joints or hair. Ask what each part costs separately before agreeing to a bundle.
Medical disclaimer. Medical Frontier is an independent educational resource. This page is for general information only and is not medical advice, diagnosis, or treatment, and does not create a doctor–patient relationship. Most regenerative therapies discussed here are not FDA-approved for the uses described and may be offered under limited exemptions or in clinical trials only. Always consult a licensed physician before making any treatment decision.